Apr 12, 2013 - 9:47 pm
At the end of the 12th cycle of the trial drug TRC 105 with avastin, the CT showed no growth in the large liver tumor and a .2cm shrinkage in the smaller one. Other "multiple" hepatic lesions continue to show signs of central necrosis (DIE, you %#!@#), and CEA is down to 2.1. No new metastisis appreciated.
Fatigue continues to be a problem as does the eribitux-like rash; these seem to be some side effects the docs are discovering with this drug. Robert and I think that this treatment also aggrevates old injuries..increased inflammation around injured joints and muscles. Docs won't say either way, but it is always asked if these areas still pain him.
Talladega race is in a few weeks....we won't be going this spring. Too much sun, late nights, food and booze; so we decided to go to the Crawfish Boil, a yearly event that always falls on Race weekend that we never go to because we are at the race. We will watch the race on TV, eat wings, and fall asleep until the last ten laps.
Best to all,